A detailed history of Raleigh Capital Management Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 43 shares of BDX stock, worth $10,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 21 104.76%
Holding current value
$10,069
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$225.07 - $246.17 $4,951 - $5,415
22 Added 104.76%
43 $10,000
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $1,867 - $1,981
8 Added 61.54%
21 $5,000
Q4 2023

Feb 21, 2024

BUY
$232.24 - $267.23 $3,019 - $3,473
13 New
13 $3,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.